首页 正文

Advances in type 2-high asthma therapy: what remains missing?

{{output}}
Introduction: Type 2-high asthma (T2HA) accounts for most severe asthma morbidity and is driven by eosinophilic, IgE- and alarmin-mediated inflammation. Although five biologics are licensed, many patients remain symptomatic, cort... ...